IRADIMED’s updated analyst narrative keeps the fair value anchor steady at $118.67, so the headline price target reference point in the model is unchanged. That level is now being echoed by bullish ...
Claritev, a healthcare technology, data, and insights company, today announced that Fernando Schwartz, Ph.D., Senior Vice President and Chief AI Officer, has been named to the DataIQ 100 North America ...